On Friday, iTeos Therapeutics Inc (ITOS) stock saw a modest uptick, ending the day at $8.81 which represents a slight increase of $0.36 or 4.26% from the prior close of $8.45. The stock opened at ...

iTeos Therapeutics has said it is evaluating with partner GlaxoSmithKline whether to conduct additional clinical trials of TIGIT drug EOS-448 following the failure of a key trial for Roche's rival ...

On Wednesday, iTeos Therapeutics Inc (ITOS) stock saw a decline, ending the day at $8.85 which represents a decrease of $-0.14 or -1.56% from the prior close of $8.99. The stock opened at $8.91 and ...

Our round-up of notable biotech financings in the last week includes a $120 million direct offering for immunology and inflammation biotech iTeos, and private rounds for Lycia, Attovia ...

iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 4,820,000 shares ...

Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide ...

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...